Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
2. No 1886
3. No-1886
1. 133208-93-2
2. No-1886
3. Lipoprotein Lipase Activator
4. Opf 009
5. Opf-009
6. Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate
7. Phosphonic Acid, ((4-(((4-bromo-2-cyanophenyl)amino)carbonyl)phenyl)methyl)-, Diethyl Ester
8. Phosphonic Acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, Diethyl Ester
9. Diethyl 4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate
10. 07h1561618
11. Diethyl 4-[(4-bromo-2-cyanoanilino)carbonyl]benzylphosphonate
12. Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
13. Ibrolipim [usan:inn]
14. 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
15. No 1886
16. Ibrolipim [usan]
17. Unii-07h1561618
18. Ibrolipim [inn]
19. N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
20. Ibrolipim (usan/inn)
21. Mls006011667
22. Chembl34234
23. Schembl493918
24. Dtxsid20157989
25. Zinc1552570
26. Akos005067076
27. Ss-3273
28. Ncgc00481428-01
29. Smr002529695
30. Hy-117549
31. Cs-0066427
32. D03747
33. D83803
34. J-006332
35. Q5984863
36. 4-diethoxyphosphinoylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
37. Diethyl4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate
38. Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate
39. Diethyl 4-[n-(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
Molecular Weight | 451.2 g/mol |
---|---|
Molecular Formula | C19H20BrN2O4P |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 450.03441 g/mol |
Monoisotopic Mass | 450.03441 g/mol |
Topological Polar Surface Area | 88.4 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hypolipidemic Agents
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)
Lipoprotein Lipase Activators
Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here. (See all compounds classified as Lipoprotein Lipase Activators.)
Ibrolipim has known human metabolites that include [4-[(4-Bromo-2-cyanophenyl)carbamoyl]phenyl]methyl-ethoxyphosphinic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
A Lipoprotein Lipase Activator manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lipoprotein Lipase Activator, including repackagers and relabelers. The FDA regulates Lipoprotein Lipase Activator manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lipoprotein Lipase Activator API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lipoprotein Lipase Activator supplier is an individual or a company that provides Lipoprotein Lipase Activator active pharmaceutical ingredient (API) or Lipoprotein Lipase Activator finished formulations upon request. The Lipoprotein Lipase Activator suppliers may include Lipoprotein Lipase Activator API manufacturers, exporters, distributors and traders.
click here to find a list of Lipoprotein Lipase Activator suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lipoprotein Lipase Activator DMF (Drug Master File) is a document detailing the whole manufacturing process of Lipoprotein Lipase Activator active pharmaceutical ingredient (API) in detail. Different forms of Lipoprotein Lipase Activator DMFs exist exist since differing nations have different regulations, such as Lipoprotein Lipase Activator USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lipoprotein Lipase Activator DMF submitted to regulatory agencies in the US is known as a USDMF. Lipoprotein Lipase Activator USDMF includes data on Lipoprotein Lipase Activator's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lipoprotein Lipase Activator USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lipoprotein Lipase Activator suppliers with USDMF on PharmaCompass.
Lipoprotein Lipase Activator Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lipoprotein Lipase Activator GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lipoprotein Lipase Activator GMP manufacturer or Lipoprotein Lipase Activator GMP API supplier for your needs.
A Lipoprotein Lipase Activator CoA (Certificate of Analysis) is a formal document that attests to Lipoprotein Lipase Activator's compliance with Lipoprotein Lipase Activator specifications and serves as a tool for batch-level quality control.
Lipoprotein Lipase Activator CoA mostly includes findings from lab analyses of a specific batch. For each Lipoprotein Lipase Activator CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lipoprotein Lipase Activator may be tested according to a variety of international standards, such as European Pharmacopoeia (Lipoprotein Lipase Activator EP), Lipoprotein Lipase Activator JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lipoprotein Lipase Activator USP).
LOOKING FOR A SUPPLIER?